CA2806519C - Compositions a base de dipropionate de beclomethasone enfermees dans des microspheres gastro-resistantes a liberation modifiee et leur procede de production - Google Patents
Compositions a base de dipropionate de beclomethasone enfermees dans des microspheres gastro-resistantes a liberation modifiee et leur procede de production Download PDFInfo
- Publication number
- CA2806519C CA2806519C CA2806519A CA2806519A CA2806519C CA 2806519 C CA2806519 C CA 2806519C CA 2806519 A CA2806519 A CA 2806519A CA 2806519 A CA2806519 A CA 2806519A CA 2806519 C CA2806519 C CA 2806519C
- Authority
- CA
- Canada
- Prior art keywords
- pharmaceutical composition
- composition according
- modified
- mixture
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La présente invention concerne des compositions pharmaceutiques à base de dipropionate de béclométhasone enfermées dans des microsphères gastro-résistantes à libération modifiée et leur utilisation par voie orale dans le cadre du traitement de pathologies inflammatoires du tractus intestinal. Lesdites microsphères contenant lesdites compositions comprennent : a) un cur constitué d'une microsphère d'un matériau inerte ; b) un premier enrobage intermédiaire comprenant du dipropionate de béclométhasone et au moins un excipient physiologiquement acceptable ; et c) un second enrobage gastro-résistant à libération modifiée. La présente invention concerne également un procédé de production desdites compositions.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI2010A001512A IT1405012B1 (it) | 2010-08-06 | 2010-08-06 | Composizioni di beclometasone dipropionato in microsfere gastroresistenti a rilascio modificato e processo per il loro ottenimento |
ITMI2010A001512 | 2010-08-06 | ||
PCT/IB2011/053430 WO2012017385A2 (fr) | 2010-08-06 | 2011-08-02 | Compositions à base de dipropionate de béclométhasone enfermées dans des microsphères gastro-résistantes à libération modifiée et leur procédé de production |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2806519A1 CA2806519A1 (fr) | 2012-02-09 |
CA2806519C true CA2806519C (fr) | 2019-03-26 |
Family
ID=43707817
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2806519A Active CA2806519C (fr) | 2010-08-06 | 2011-08-02 | Compositions a base de dipropionate de beclomethasone enfermees dans des microspheres gastro-resistantes a liberation modifiee et leur procede de production |
Country Status (10)
Country | Link |
---|---|
US (1) | US10028917B2 (fr) |
EP (2) | EP2600852A2 (fr) |
CA (1) | CA2806519C (fr) |
CY (1) | CY1120931T1 (fr) |
DK (1) | DK3009130T3 (fr) |
ES (1) | ES2701264T3 (fr) |
HK (1) | HK1223570A1 (fr) |
IT (1) | IT1405012B1 (fr) |
PT (1) | PT3009130T (fr) |
WO (1) | WO2012017385A2 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201202433D0 (en) | 2012-02-13 | 2012-03-28 | Diurnal Ltd | Controlled drug release |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1981002671A1 (fr) * | 1980-03-20 | 1981-10-01 | Ferring Farma Lab | Composition pharmaceutique et methode de traitement de la colite ulcereuse et la maladie de crohn par voie orale |
IL92343A0 (en) * | 1988-12-20 | 1990-07-26 | Gist Brocades Nv | Granulate for multiparticulate controlled release oral compositions,their preparation and oral pharmaceutical compositions containing them |
JP3469926B2 (ja) * | 1993-11-04 | 2003-11-25 | 太田製薬株式会社 | 大腸内放出型医薬製剤用粒状物 |
US5958458A (en) | 1994-06-15 | 1999-09-28 | Dumex-Alpharma A/S | Pharmaceutical multiple unit particulate formulation in the form of coated cores |
AU710109B2 (en) * | 1996-01-16 | 1999-09-16 | Ap Pharma, Inc. | Topical delivery of drugs to the lower gastrointestinal tract |
US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
DE60237363D1 (de) * | 2001-03-15 | 2010-09-30 | Soligenix Inc | Verfahren zur behandlung von entzündlichen erkrankungen des verdauungstrakts mit topisch wirksamen kortikosteroiden |
US8238554B2 (en) | 2004-07-22 | 2012-08-07 | Sanyo Electric Co., Ltd. | Method for transmission/reception of contents usage right information in encrypted form, and device thereof |
US9149439B2 (en) | 2005-03-21 | 2015-10-06 | Sandoz Ag | Multi-particulate, modified-release composition |
US20080081070A1 (en) * | 2006-09-15 | 2008-04-03 | Auriga Laboratories, Inc. | Pharmaceutical formulation with enhanced solubility for the delivery of corticosteroids |
-
2010
- 2010-08-06 IT ITMI2010A001512A patent/IT1405012B1/it active
-
2011
- 2011-08-02 EP EP11754741.4A patent/EP2600852A2/fr not_active Ceased
- 2011-08-02 WO PCT/IB2011/053430 patent/WO2012017385A2/fr active Application Filing
- 2011-08-02 EP EP15195081.3A patent/EP3009130B1/fr active Active
- 2011-08-02 DK DK15195081.3T patent/DK3009130T3/en active
- 2011-08-02 ES ES15195081T patent/ES2701264T3/es active Active
- 2011-08-02 CA CA2806519A patent/CA2806519C/fr active Active
- 2011-08-02 US US13/814,642 patent/US10028917B2/en active Active
- 2011-08-02 PT PT15195081T patent/PT3009130T/pt unknown
-
2016
- 2016-10-18 HK HK16112003.2A patent/HK1223570A1/zh unknown
-
2018
- 2018-11-27 CY CY181101257T patent/CY1120931T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
PT3009130T (pt) | 2018-12-14 |
EP3009130A1 (fr) | 2016-04-20 |
US10028917B2 (en) | 2018-07-24 |
ES2701264T3 (es) | 2019-02-21 |
EP3009130B1 (fr) | 2018-10-10 |
HK1223570A1 (zh) | 2017-08-04 |
ITMI20101512A1 (it) | 2012-02-07 |
CY1120931T1 (el) | 2019-12-11 |
IT1405012B1 (it) | 2013-12-16 |
CA2806519A1 (fr) | 2012-02-09 |
WO2012017385A3 (fr) | 2012-04-19 |
WO2012017385A2 (fr) | 2012-02-09 |
US20130142880A1 (en) | 2013-06-06 |
EP2600852A2 (fr) | 2013-06-12 |
DK3009130T3 (en) | 2018-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5383183B2 (ja) | ロフルミラストを含有する矯味された剤形 | |
ES2452265T3 (es) | Composiciones para la administración oral de corticosteroides | |
WO2014128233A1 (fr) | Formulations de stéroïdes administrées par voie orale destinées à être utilisées pour le traitement d'une fibrose intestinale | |
EP3498264B1 (fr) | Préparation pharmaceutique pour administration orale à vitesse de dissolution contrôlée, la préparation comprenant des pastilles à libération prolongée contenant du chlorhydrate de tamsulosine | |
CN103006607B (zh) | 一种兰索拉唑肠溶片及其制备方法 | |
JP5479909B2 (ja) | 新規製剤 | |
KR20070115918A (ko) | 멀티플 유닛형 경구 서방성 제제 및 그 제조방법 | |
JP5813391B2 (ja) | 粒子製剤の製造方法 | |
JP2002526437A (ja) | アジテーション非依存性薬学的マルチプル−ユニット持効性製剤およびその製法 | |
KR20150123248A (ko) | 유기 화합물의 제제 | |
CN102552256A (zh) | 一种艾普拉唑肠溶胶囊及其制备方法 | |
WO2008010524A1 (fr) | Procédé servant à produire des granules élémentaires sphériques contenant un médicament aisément soluble dans l'eau | |
CN112315934B (zh) | 白头翁皂苷b4肠溶片的制备工艺 | |
CA2806519C (fr) | Compositions a base de dipropionate de beclomethasone enfermees dans des microspheres gastro-resistantes a liberation modifiee et leur procede de production | |
CN106511291A (zh) | 一种盐酸阿考替胺缓释片剂及其制备方法 | |
EP3981469A1 (fr) | Agent thérapeutique contre la goutte ou l'hyperuricémie | |
EP2461802B2 (fr) | Compositions granulaires à libération contrôlée contenant de la mésalazine et procédé de fabrication associé | |
US20220273619A1 (en) | Pharmaceutical formulations comprising sodium palmitoyl-l-prolyl-l-prolylglycyl-l-tyrosinate and methods for preparing the same | |
JP2007332102A (ja) | 腸溶性顆粒剤及びその製造方法 | |
JP3122478B2 (ja) | 下部消化管放出型経口製剤 | |
CN112494461A (zh) | 一种美沙拉嗪肠溶缓释药物组合物及制备方法 | |
CN102552214A (zh) | 一种艾普拉唑肠溶胶囊及其制备方法 | |
EP1100481B1 (fr) | Formulations pharmaceutiques servant a traiter la maladie intestinale inflammatoire | |
JP2022535748A (ja) | ピリミジニルアミノピラゾール化合物の調節放出製剤および処置方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |
Effective date: 20160524 |